The FDA has approved Atzumi (dihydroergotamine) nasal powder for the acute treatment of migraine with or without aura in adults.

It’s election this weekend in Australia, and we’re all preparing to dictate what the next three years of our lives will look ...

Results of a large, global clinical trial spanning five continents with over 1,700 patients with bronchiectasis, published ...

DHE is a migraine-specific acute medication first approved in 1946. The FDA's approval of the nasal powder formulation, ...

Learn about the different types of colds, their symptoms, and how to manage each variation effectively. Stay informed and ...